Loss of myelin-associated glycoprotein in kearns-sayre syndrome.

ABSTRACT:

Objective

To explore myelin components and mitochondrial changes within the central nervous system in patients with well-characterized mitochondrial disorders due to nuclear DNA or mitochondrial DNA (mtDNA) mutations.

Design

Immunohistochemical analysis, histochemical analysis, mtDNA sequencing, and real-time and long-range polymerase chain reaction were used to determine the pathogenicity of mtDNA deletions.

Setting

Department of Clinical Pathology, Columbia University Medical Center, and Newcastle Brain Tissue Resource.

Patients

Seventeen patients with mitochondrial disorders and 7 controls were studied from August 1, 2009, to August 1, 2010.

Main outcome measure

Regions of myelin-associated glycoprotein (MAG) loss.

Results

Myelin-associated glycoprotein loss in Kearns-Sayre syndrome was associated with oligodendrocyte loss and nuclear translocation of apoptosis-inducing factor, whereas inflammation, neuronal loss, and axonal injury were minimal. In a Kearns-Sayre syndrome MAG loss region, high levels of mtDNA deletions together with cytochrome- c oxidase-deficient cells and loss of mitochondrial respiratory chain subunits (more prominent in the white than gray matter and glia than axons) confirmed the pathogenicity of mtDNA deletions.

Conclusion

Primary mitochondrial respiratory chain defects affecting the white matter, and unrelated to inflammation, are associated with MAG loss and central nervous system demyelination.

SUBMITTER: Lax NZ 

PROVIDER: S-EPMC3672633 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature